Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors. - Rohrberg KS; Lopez JS; Milhem MM; Blank CU; Reijers I; Thistlethwaite F; Plummer R; Piha-Paul SA; Jänne PA; Shum E; Shaw HM; Debruyne PR; et al. (Cancer research communications, 2025)